Human HepaRG liver spheroids: cold storage protocol and study on pyridinium oxime-induced hepatotoxicity in vitro.
Autor: | Horn G; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany., Kranawetvogl T; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany., John H; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany., Weigel C; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany., Rauen U; Institut für Physiologische Chemie, Universitätsklinikum, Hufelandstrasse 55, 45122, Essen, Germany., Worek F; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany., Wille T; Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany. Electronic address: TimoWille@bundeswehr.org. |
---|---|
Jazyk: | angličtina |
Zdroj: | Chemico-biological interactions [Chem Biol Interact] 2023 Jan 05; Vol. 369, pp. 110285. Date of Electronic Publication: 2022 Nov 26. |
DOI: | 10.1016/j.cbi.2022.110285 |
Abstrakt: | Oximes play an essential role in the therapy of organophosphorus compound (OP) poisoning by reactivating inhibited acetylcholinesterase. Impairment of liver function was observed in OP poisoning and associated with obidoxime treatment by some reports. In this study human three-dimensional HepaRG spheroids were used as complex in vitro model to investigate oxime-induced liver toxicity. In this context, cold storage of liver spheroids at 4 °C in standard culture medium and in optimized tissue preservation solutions of up to 72 h was assessed. Cold storage in standard culture medium resulted in a complete loss of viability whereas an optimized tissue preservation solution preserved viability. Separately from that liver spheroids were exposed to the four oximes pralidoxime, obidoxime, HI-6, MMB-4 and cytotoxicity (effective concentration, EC Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ursula Rauen reports a relationship with Köhler Chemie that includes: consulting or advisory. U.R. obtained consulting fees from Dr. Franz Köhler Chemie GmbH, Bensheim, Germany. Dr. Franz Köhler Chemie holds a patent on a preservation solution covering the cold storage solutions used in this study. The other authors declare that there are no conflicts of interest. (Copyright © 2022. Published by Elsevier B.V.) |
Databáze: | MEDLINE |
Externí odkaz: |